| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 Oct 2025 | 22 Oct 2025 |
| Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2025 ,inter alia, to consider and approve the un-audited financial results of the Company for the quarter and half-year ended September 30, 2025 Approval of Interim Dividend of Rs.3 per equity share for the financial year 2025-26. As per letter enclosed. (As Per BSE Announcement Dated on:30.10.2025) | ||
| Board Meeting | 27 Aug 2025 | 24 Aug 2025 |
| Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2025 inter alia to consider and approve the proposal for raising of funds up to ? 700000000 (Indian Rupees seventy crores only) by issuance of equity shares of the Company to Dr. Agarwals Health Care Limited (promoter of the Company) by way of preferential allotment in accordance with the provisions of the Companies Act 2013 SEBI Listing Regulations SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 and other applicable laws and subject to such regulatory/ statutory approvals and the approval of shareholders of the Company as may be required in this regard. As per the letter enclosed. (As per BSE Announcement Dated on 27/08/2025) | ||
| Board Meeting | 12 Aug 2025 | 30 Jul 2025 |
| Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the unaudited financial results for the quarter ended June 30 2025. As per the letter enclosed. (As Per BSE Announcement Dated on: 12/08/2025) | ||
| Board Meeting | 28 May 2025 | 20 May 2025 |
| Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31 2025 and recommendation of Final Dividend if any for the Financial Year 2024-25. As intimated earlier in terms of the Companys Code of Internal Procedures and Conduct for Prohibition of Insider Trading the Trading Window will remain closed until 48 hours after the announcement of the aforesaid financial results. As per the letter enclosed. (As per BSE Announcement Dated on 28/05/2025) | ||
| Board Meeting | 14 Feb 2025 | 7 Feb 2025 |
| DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended December 31 2024 As per the letter enclosed. (As Per BSE Announcement Dated on 14.02.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.